Seven new oxime-based acetylcholinesterase reactivators were compared with three currently available ones (obidoxime, trimedoxime, HI-6) for their ability to lessen cholinesterase inhibition in blood and brain of cyclosarin-treated rats. Oximes were given at doses of 5% their LD(50) along with 21 mg/kg atropine five min before the LD(50) of cyclosarin (120 ug/kg) was administered. Blood and brain samples were collected 30 minutes later. The greatest difference between acetylcholinesterase inhibition in blood of cyclosarin-treated rats was found after administration of HI-6 (40%), compared to 22% for trimedoxime and 6% for obidoxime. Only two of the seven newly synthesized oximes had any effect (K203 at 7%, K156 at 5%). Effective oximes against cyclosarin-inhibited plasma butyrylcholinesterase were HI-6 (42%), trimedoxime (11%), and K156 (4%). The oximes were less effective in brain than in blood, with reactivation values for HI-6 30% against acetylcholinesterase and 10% against butyrylcholinesterase. Values for newly synthesized oximes were less than 10% for K206, K269 and K203.

Center of Advanced Studies Faculty of Military Health Sciences Hradec Kralove Czech Republic

Department of Chemistry Faculty of Sciences J E Purkinje University Horeni 13 400 96 Usti nad Labem Czech Republic

Department of Toxicology Faculty of Military Health Sciences Trebesska 1575 500 01 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Jokanovic M, Prostran M. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr. Med. Chem. 2009;16:2177–2188. PubMed

Marrs TC. Organophosphate poisoning. Pharmacol. Ther. 1993;58:51–66. PubMed

Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 1994;14:317–331. PubMed

Marrs TC, Rice P, Vale JA. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev. 2006;25:297–323. PubMed

Reiter G, Koller M, Thiermann H, Dorandeu F, Mikler J, Worek F. Development and application of procedures for the highly sensitive quantification of cyclosarin enantiomers in hemolysed swine blood samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007;859:9–15. PubMed

Maxwell DM, Koplovitz I, Worek F, Sweeney RE. A structure-activity analysis of the variation in oxime efficacy against nerve agents. Toxicol Appl Pharmacol. 2008;231:157–164. PubMed

Kovarik Z, Calic M, Sinko G, Bosak A, Berend S, Vrdoljak AL, Radic B. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem. Biol. Interact. 2008;175:173–179. PubMed

Wilson IB, Sondheimer F. A specific antidote against lethal alkyl phosphate intoxication. V. Antidotal properties. Arch Biochem Biophys. 1957;69:468–474. PubMed

Kassa J, Kuca K, Karasova J, Musilek K. The development of new oximes and the evaluation of thein reactivating, therapeutic and neuroprotective efficacy against tabun. Mini Rev. Med. Chem. 2008;8:1134–1143. PubMed

Berend S, Vrdoljak AL, Radic B, Kuca K. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning. Chem. Biol. Interact. 2008;175:413–416. PubMed

Kuca K, Musilek K, Paar M, Jun D, Stodulka P, Hrabinova M, Marek J. Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide-a new nerve agent reactivator. Molecules. 2007;12:1964–1974. PubMed PMC

Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuca K. Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203) J Med Chem. 2007;50:5514–5518. PubMed

Musilek K, Holas O, Jun D, Dohnal V, Gunn-Moore F, Opletalova V, Dolezal M, Kuca K. Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase. Bioorg. Med. Chem. 2007;15:6733–6741. PubMed

Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Opletalova V, Dolezal M. Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J. Enzyme Inhib. Med. Chem. 2008;23:70–76. PubMed

Kuca K, Jun D, Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini Rev. Med. Chem. 2006;6:269–277. PubMed

Bieger D, Wasserman O. Ionization constants of cholinesterase-reactivating bispyridinium aldoximes. J. Pharm. Pharmacol. 1967;19:844–847. PubMed

Kuca K, Patocka J. Reactivation of the cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J. Enzyme Inhib. Med. Chem. 2004;19:39–43. PubMed

Zdarova Karasova J, Kassa J, Jung YS, Musilek K, Pohanka M, Kuca K. Effect of several new and currently available oxime cholinesterase reactivators on tabun-inhibited rats. Int J Mol Sci. 2008;9:2243–2252. PubMed PMC

Kassa J, Jun D, Karasova J, Bajgar J, Kuca K. A comparison of reactivating efficacy of newly developed oximes (K 074, K 075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats. Chem. Biol. Interact. 2008;175:425–427. PubMed

Kassa J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology. 1999;132:111–118. PubMed

Patocka J, Cabal J, Kuca K, Jun D. Oxime reactivation of acetylcholinesterase inhibited by toxic organophosphorus ester: In vitro kinetics and thermodynamics. J. Appl. Biomed. 2005;3:91–99.

Kuca K, Bielavsky J, Cabal J, Bielavska M. Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoyl-pyridinium)-propane dibromide. Tetrahedron Lett. 2003;44:3123–3125.

Bajgar J. Biological monitoring of exposure to nerve agents. Br. J. Ind. Med. 1992;49:648–653. PubMed PMC

Bartosova L, Kuca K, Kunesova G, Jun D. The acute toxicity of the acetylcholinesterase reactivators in mice in relation to their structure. Neurotox. Res. 2006;9:291–296. PubMed

Tallarida R, Murray R. Manual of pharmacological calculation with computer programs. 2nd. Springer-Verlag; New York, NY, USA: 1987. p. 145.

Zdarova Karasova J, Kuca K, Jun D, Bajgar J. Using of Ellman method for In vivo testing of cholinesterases' activities (In Czech) Chem Listy. 2009 in press.

Ellman GL, Coutney DK, Andres V, Fear-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95. PubMed

Pohanka M, Jun D, Kuca K. Improvement of acetylcholinesterase-based assay for organophosphates in way of identification by reactivators. Talanta. 2008;77:451–454. PubMed